Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
OA01 - The Impact of COVID-19 on Patients with Lung Cancer
- 08:15 - 09:15
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Enriqueta Felip
-
+
OA01.01 - Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls
08:15 - 08:25 | Presenter: Jorge E Gomez
- Abstract
Loading... -
+
OA01.02 - Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study
08:25 - 08:35 | Presenter: Luca Cantini
- Abstract
Loading... -
+
OA01.03 - Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience
08:35 - 08:45 | Presenter: Lucie Brigitte Marie Hijmering-Kappelle
- Abstract
Loading... -
+
OA01.04 - Discussant
08:45 - 08:55 | Presenter: Suresh Ramalingam
- Abstract
No abstract available for this presentation
-
+
OA01.05 - Live Discussion with Speakers
08:55 - 09:05
- Abstract
No abstract available for this presentation
-
+
MA04 - Current Status and Future Prospects of Pleural Mesothelioma and Thymoma
- 10:45 - 11:45
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
-
+
MA04.07 - Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
11:25 - 11:30 | Presenter: Susana Cedres
- Abstract
Loading...
-
+
FP09 - Novel Therapeutics and Targeted Therapies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Novel Therapeutics and Targeted Therapies
-
+
FP09.01 - Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy
00:00 - 00:00 | Presenter: Pasi A. Janne
- Abstract
Loading...
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P45.03 - Tepotinib in Patients with MET exon 14 (METex14) Skipping NSCLC as Identified by Liquid (LBx) or Tissue (TBx) biopsy
00:00 - 00:00 | Presenter: Enriqueta Felip
- Abstract
Loading...
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 06:30 - 08:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
07:04 - 07:14 | Presenter: Nasser Altorki
- Abstract
Loading...
-
+
OA09 - Expanding Immunotherapy Options for Non-Small Cell Lung Cancers
- 09:30 - 10:30
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
- Moderators:Rina Hui
-
+
OA09.01 - First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA
09:30 - 09:40 | Presenter: David Carbone
- Abstract
Loading... -
+
OA09.02 - Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases
09:40 - 09:50 | Presenter: Ernest Nadal
- Abstract
Loading...
-
+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- 14:30 - 16:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
15:04 - 15:14 | Presenter: Nasser Altorki
- Abstract
Loading...
-
+
MA14 - Pathologic Patterns, Genomic Alterations and Targeted Therapies in NSCLC
- 18:45 - 19:45
- 9/13/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
MA14.02 - RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study
18:50 - 18:55 | Presenter: Fernando Lopez-Rios
- Abstract
Loading...
